Guidelines for the treatment of hemophilia
Meili, E.O.; Blättler, W.; Jacky, E.; Schneider, W.; Kaufmann, L.; Sigg, P.; Frick, P.G.
Therapeutische Umschau. Revue Therapeutique 36(4): 345-358
1979
ISSN/ISBN: 0040-5930 PMID: 313084 Document Number: 146296
Document emailed within 1 workday
Related Documents
Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483Ingerslev, J.; Christiansen, S.E.; Kristensen, T.; Wallevik, K.; Bernvil, S.S. 1985: Treatment of hemophilia a and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP Ugeskrift for Laeger 147(45): 3592-3594
Levine, W.C.; Berg, A.O.; Johnson, R.E.; Rolfs, R.T.; Stone, K.M.; Hook, E.W.; Handsfield, H.H.; Holmes, K.K.; Islam, M.Q.; Piot, P. 1994: Development of sexually transmitted diseases treatment guidelines, 1993. New methods, recommendations, and research priorities. STD Treatment Guidelines Project Team and Consultants Sexually Transmitted Diseases 21(2 Suppl): S96-101
Levine, W.C.; Berg, A.O.; Johnson, R.E.; Rolfs, R.T.; Stone, K.M.; Hook, E.W.; Handsfield, H.H.; Holmes, K.K.; Islam, M.Q.; Piot, P. 1994: Development of sexually transmitted diseases treatment guidelines, 1993. New methods, recommendations, and research priorities. STD Treatment Guidelines Project Team and Consultants Sexually Transmitted Diseases 21(2 Suppl): S96-101
Xu, H. 2010: Evidence-based guidelines for diagnosis and treatment of common renal diseases in children (for trial) (VII): guidelines for the diagnosis and treatment of urinary tract infection Zhonghua Er Ke Za Zhi 48(11): 814-816
Lillicrap, D.P.; Bridge, P.J.; Giles, A.R. 1990: Organization of a hemophilia genetic screening program. Ontario Hemophilia Study Group Progress in Clinical and Biological Research 324: 19-28
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Nichols, S.; Mahoney, E.M.; Sirois, P.A.; Bordeaux, J.D.; Stehbens, J.A.; Loveland, K.A.; Amodei, N. 2000: HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the Hemophilia Growth and Development Study Journal of Pediatric Psychology 25(8): 545-556
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Jones, P. 1979: Organization of hemophilia therapy. the role of the hemophilia center Sangre 24(5-C): 998-1004
Girolami, A.; Dal Bo Zanon, R.; Procidano, M. 1981: Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1 Folia Haematologica 108(6): 863-871
Gazzard, B.; Moyle, G. 1998: 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee Lancet 352(9124): 314-316
Magallón Martínez, M.; Ortega, F.; Pinilla, J. 1992: AIDS and hemophilia: experience in the La Paz Hemophilia Center Haemostasis 22(5): 281-292
Huang, X.J. 2017: Evaluate the role of the guidelines from the development of "Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers" in China Zhonghua Nei Ke Za Zhi 56(6): 393-394
Aledort, L.M.; Kroner, B.; Mariani, G. 2000: Hemophilia treatment. Immune tolerance induction: treatment duration analysis and economic considerations Haematologica 85(10 Suppl): 83-85
Piguet, H. 1974: Treatment of hemophilia Revue de l'Infirmiere 24(5): 399-401
Bellucci, S. 1985: Treatment of hemophilia Revue de l'Infirmiere 35(5): 34-37
Walker, I.; Poon, M.C. 1992: Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group Lancet 339(8784): 61-62
Talstad, I.; Nokleby, K.A.; Borchgrevink, H.C.; Egeberg, O. 1976: Surgical treatment in hemophilia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 96(12): 692-695